Citigroup Healthcare News

This is selected healthcare news for Citigroup, which is filed under Capital Firms. There are 84.6K news items for this page. Citigroup is occasionally combined with Digital Health, Community Health and Wolfe Research in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/25/2022 Citigroup Begins Coverage on Gracell Biotechnologies (NASDAQ:GRCL) - Mayfield Recorder
Citigroup initiated coverage on shares of Gracell Biotechnologies ( NASDAQ:GRCL ‚Ai Get Rating ) in a report issued on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $12.00 price objective on the stock. Other analysts also recently issued research reports about the stock. Cantor Fitzgerald began coverage ...
Mayfield Recorder
9/25/2022 Gracell Biotechnologies (NASDAQ:GRCL) Research Coverage Started at Citigroup
Citigroup initiated coverage on shares of Gracell Biotechnologies ( NASDAQ:GRCL ‚Ai Get Rating ) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $12.00 price objective on the stock. Several other brokerages have also recently issued reports on GRCL ...
slatersentinel.com
9/25/2022 Gracell Biotechnologies (NASDAQ:GRCL) Research Coverage Started at Citigroup
Citigroup initiated coverage on shares of Gracell Biotechnologies ( NASDAQ:GRCL ‚Ai Get Rating ) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $12.00 price objective on the stock. Several other brokerages have also recently issued reports on GRCL ...
The Markets Daily
9/24/2022 Gracell Biotechnologies (NASDAQ:GRCL) Coverage Initiated at Citigroup - Watch List News
Investment analysts at Citigroup initiated coverage on shares of Gracell Biotechnologies ( NASDAQ:GRCL ‚Ai Get Rating ) in a report released on Thursday, MarketBeat Ratings reports. The firm set a ‚Aubuy‚Au rating and a $12.00 price target on the stock. Citigroup's price objective would suggest a potential upside of ...
watchlistnews.com
9/24/2022 Gracell Biotechnologies (NASDAQ:GRCL) Receives New Coverage from Analysts at Citigroup
Analysts at Citigroup started coverage on shares of Gracell Biotechnologies ( NASDAQ:GRCL ‚Ai Get Rating ) in a report released on Thursday, Marketbeat.com reports. The brokerage set a ‚Aubuy‚Au rating and a $12.00 price target on the stock. Citigroup's price target would indicate a potential upside of 378.09% from ...
American Banking News
9/24/2022 Gracell Biotechnologies (NASDAQ:GRCL) Coverage Initiated at Citigroup dispatchtribunal.com
9/23/2022 Citigroup CEO says the company is ‘very mindful’ of costly commutes Fortune
9/23/2022 Gracell Biotechnologies (NASDAQ:GRCL) Coverage Initiated by Analysts at Citigroup - Ticker Report Ticker Report
9/22/2022 Healthcare Realty Trust (NYSE:HR) Rating Increased to Buy at Citigroup - Slater Sentinel slatersentinel.com
9/22/2022 Gracell Biotechnologies (NASDAQ:GRCL) Receives New Coverage from Analysts at Citigroup zolmax.com
9/22/2022 Gracell Biotechnologies (NASDAQ:GRCL) Receives New Coverage from Analysts at Citigroup baseballnewssource.com
9/22/2022 Change Healthcare (NASDAQ:CHNG) Stock Rating Lowered by Citigroup - Watch List News watchlistnews.com
9/20/2022 Healthcare Realty Trust (NYSE:HR) Upgraded to “Buy” by Citigroup baseballnewssource.com
9/19/2022 Citigroup Cuts Innate Pharma (NASDAQ:IPHA) Price Target to $12.00 - The Cerbat Gem thecerbatgem.com
9/18/2022 : Work hard, play harder: Citigroup sent 27 lucky junior bankers to toil beside one of Spain's finest beaches outperformdaily.com
9/18/2022 Work Hard, Play Harder: Citigroup Sent 27 Lucky Junior Bankers To Toil Beside One Of Spain’s Finest Beaches - Public News Time publicnewstime.com
9/18/2022 Work hard, play harder: Citigroup sent 27 lucky junior bankers to toil beside one of Spain’s finest beaches - News AKMI newsakmi.com
9/18/2022 Innate Pharma (NASDAQ:IPHA) Given New $12.00 Price Target at Citigroup - Ticker Report Ticker Report
9/18/2022 Citigroup Lowers Innate Pharma (NASDAQ:IPHA) Price Target to $12.00 modernreaders.com
9/17/2022 Innate Pharma (NASDAQ:IPHA) Price Target Cut to $12.00 by Analysts at Citigroup defenseworld.net
9/16/2022 American Healthcare REIT Files Registration Statement to Pursue Underwritten Public Offering in Conjunction with the Intended Listing of its Common Stock on the New York Stock Exchange PR Newswire
9/16/2022 Birch Capital Management LLC Sells 1,104 Shares of Universal Health Services, Inc. (NYSE:UHS) slatersentinel.com
9/16/2022 Birch Capital Management LLC Sells 1,104 Shares of Universal Health Services, Inc. (NYSE:UHS) Daily Political
9/16/2022 American Trust Purchases 16,555 Shares of Exact Sciences Co. (NASDAQ:EXAS) - Ticker Report Ticker Report
9/15/2022 Citigroup lifts Aflac Incorporated [AFL] price estimate. Who else is bullish? dbtnews.com